BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31635932)

  • 1. Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.
    Grädler U; Schwarz D; Blaesse M; Leuthner B; Johnson TL; Bernard F; Jiang X; Marx A; Gilardone M; Lemoine H; Roche D; Jorand-Lebrun C
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126717. PubMed ID: 31635932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA
    Woolford AJ; Day PJ; Bénéton V; Berdini V; Coyle JE; Dudit Y; Grondin P; Huet P; Lee LY; Manas ES; McMenamin RL; Murray CW; Page LW; Patel VK; Potvain F; Rich SJ; Sang Y; Somers DO; Trottet L; Wan Z; Zhang X
    J Med Chem; 2016 Dec; 59(23):10738-10749. PubMed ID: 27933945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.
    Guo HX; Wang F; Yu KQ; Chen J; Bai DL; Chen KX; Shen X; Jiang HL
    Acta Pharmacol Sin; 2005 Oct; 26(10):1201-11. PubMed ID: 16174436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.
    Park I; Londhe AM; Lim JW; Park BG; Jung SY; Lee JY; Lim SM; No KT; Lee J; Pae AN
    J Comput Aided Mol Des; 2017 Oct; 31(10):929-941. PubMed ID: 28913661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pushing the Limits of Detection of Weak Binding Using Fragment-Based Drug Discovery: Identification of New Cyclophilin Binders.
    Georgiou C; McNae I; Wear M; Ioannidis H; Michel J; Walkinshaw M
    J Mol Biol; 2017 Aug; 429(16):2556-2570. PubMed ID: 28673552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors.
    Valasani KR; Vangavaragu JR; Day VW; Yan SS
    J Chem Inf Model; 2014 Mar; 54(3):902-12. PubMed ID: 24555519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies of ground- and transition-state analogue inhibitors of cyclophilin.
    Wang HC; Kim K; Bakhtiar R; Germanas JP
    J Med Chem; 2001 Aug; 44(16):2593-600. PubMed ID: 11472213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serendipitous discovery of a potent influenza virus a neuraminidase inhibitor.
    Mohan S; Kerry PS; Bance N; Niikura M; Pinto BM
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1076-80. PubMed ID: 24339250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering novel chemical inhibitors of human cyclophilin A: virtual screening, synthesis, and bioassay.
    Li J; Chen J; Gui C; Zhang L; Qin Y; Xu Q; Zhang J; Liu H; Shen X; Jiang H
    Bioorg Med Chem; 2006 Apr; 14(7):2209-24. PubMed ID: 16307882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approach of fragment-based lead discovery applied to renin inhibitors.
    Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
    Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking and ligand specificity in fragment-based inhibitor discovery.
    Chen Y; Shoichet BK
    Nat Chem Biol; 2009 May; 5(5):358-64. PubMed ID: 19305397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and molecular basis of subtype-selective cyclophilin inhibitors.
    Peterson AA; Rangwala AM; Thakur MK; Ward PS; Hung C; Outhwaite IR; Chan AI; Usanov DL; Mootha VK; Seeliger MA; Liu DR
    Nat Chem Biol; 2022 Nov; 18(11):1184-1195. PubMed ID: 36163383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel 7-azaindoles as PDK1 inhibitors.
    Wucherer-Plietker M; Merkul E; Müller TJJ; Esdar C; Knöchel T; Heinrich T; Buchstaller HP; Greiner H; Dorsch D; Finsinger D; Calderini M; Bruge D; Grädler U
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3073-3080. PubMed ID: 27217002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis.
    Shore ER; Awais M; Kershaw NM; Gibson RR; Pandalaneni S; Latawiec D; Wen L; Javed MA; Criddle DN; Berry N; O'Neill PM; Lian LY; Sutton R
    J Med Chem; 2016 Mar; 59(6):2596-611. PubMed ID: 26950392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based discovery of focal adhesion kinase inhibitors.
    Grädler U; Bomke J; Musil D; Dresing V; Lehmann M; Hölzemann G; Greiner H; Esdar C; Krier M; Heinrich T
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5401-9. PubMed ID: 23973211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
    Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
    J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution crystal structures of two crystal forms of human cyclophilin D in complex with PEG 400 molecules.
    Valasani KR; Carlson EA; Battaile KP; Bisson A; Wang C; Lovell S; ShiDu Yan S
    Acta Crystallogr F Struct Biol Commun; 2014 Jun; 70(Pt 6):717-22. PubMed ID: 24915078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic combinatorial self-assembly of cyclophilin hCyp-18 ligands through oxorhenium coordination.
    Clavaud C; Le Gal J; Thai R; Moutiez M; Dugave C
    Chembiochem; 2008 Jul; 9(11):1823-9. PubMed ID: 18604836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
    Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
    Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-Based Discovery of Novel Potent Sepiapterin Reductase Inhibitors.
    Alen J; Schade M; Wagener M; Christian F; Nordhoff S; Merla B; Dunkern TR; Bahrenberg G; Ratcliffe P
    J Med Chem; 2019 Jul; 62(13):6391-6397. PubMed ID: 31244106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.